<img src="https://www.syndicate-365-perception.com/800132.png" style="display:none;">

Using Nanotherapy To Treat Low-Grade Canine Mast Cell Tumors: Evaluation Of Efficacy And Safety

by Lisa Parshley, DVM, PhD, DACVIM

Veterinary oncologist Lisa Parshley guides you guides you through an exciting new study using gold nanoparticles and laser light to treat canine low-grade mast cell tumors (MCTs) in this webinar. 

Nanoparticles can be used to passively target these tumors and, when combined with laser light and a specialized handpiece for delivery, can effectively ablate low-grade MCTs while sparing surrounding healthy tissues. She covers the results of this study and the basis for this new option for localized treatment. 

Learning Objectives

  • What nanoparticles are and how they are used in oncology

  • Results from a published multicenter study using Nanotherapy to treat canine low-grade mast cell tumors

  • An introduction to how Nanotherapy is performed on low-grade MCTs

  • What to expect with treatment

  • Ideal MCTs to target for Nanotherapy

 

 

Please note that the original speaker will not be available to answer questions submitted for on-demand webinars. Our medical team will answer any questions to the best of their availability, but this may not be possible depending on the question submitted.